Tag: Vaccines
Rollout of Pfizer COVID-19 Vaccine Saved Lives, Health Care Dollars
Model shows vaccine tied to prevention of 110,000 deaths and a resulting $30.4 billion direct health care cost savings
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant
Company Hid Problems With COVID-19 Vaccines From FDA
Nearly 400 million doses of vaccine made by Emergent had to be destroyed 'due to poor quality control'
NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine
The phase 1 trial is expected to last four years and enroll 40 participants
FDA Limits Use of J&J COVID-19 Vaccine Due to Blood Clot Risk
With safer two-dose vaccines such as Pfizer and Moderna widely available, the one-dose J&J shot should be limited
Plant-Based Recombinant COVID-19 Vaccine Found to Be Effective
Vaccine efficacy ranged from 69.5 percent against symptomatic infection to 78.8 percent against moderate-to-severe disease
